Organisation of Prostate Cancer Services in the English National Health Service.

[1]  Steven L. Chang,et al.  The impact of robotic surgery on the surgical management of prostate cancer in the USA , 2015, BJU international.

[2]  C. Gross,et al.  Perceptions of Active Surveillance and Treatment Recommendations for Low-risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and Urologists , 2014, Medical care.

[3]  D. Neal,et al.  The National Prostate Cancer Audit - introducing a new generation of cancer audit. , 2014, Clinical oncology (Royal College of Radiologists (Great Britain)).

[4]  D. Neal,et al.  The first national clinical audit of prostate cancer care , 2013, BJU international.

[5]  Jason Wang,et al.  Stereotactic body radiotherapy for localized prostate cancer: pooled analysis from a multi-institutional consortium of prospective phase II trials. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[6]  Thomas Wiegel,et al.  Guidelines on Prostate Cancer , 2013 .

[7]  P. Hoskin,et al.  High-dose-rate brachytherapy alone for localized prostate cancer in patients at moderate or high risk of biochemical recurrence. , 2012, International journal of radiation oncology, biology, physics.

[8]  J. McCabe,et al.  UK radical prostatectomy outcomes and surgeon case volume: based on an analysis of the British Association of Urological Surgeons Complex Operations Database , 2012, BJU international.

[9]  G. Bevan,et al.  Does competition between hospitals improve clinical quality? A review of evidence from two eras of competition in the English NHS , 2011, BMJ : British Medical Journal.

[10]  J. Blasko,et al.  Fifteen-year biochemical relapse-free survival, cause-specific survival, and overall survival following I(125) prostate brachytherapy in clinically localized prostate cancer: Seattle experience. , 2011, International journal of radiation oncology, biology, physics.

[11]  Thomas Hambrock,et al.  Prostate cancer: multiparametric MR imaging for detection, localization, and staging. , 2011, Radiology.

[12]  Yipeng Hu,et al.  Characterizing clinically significant prostate cancer using template prostate mapping biopsy. , 2011, The Journal of urology.

[13]  T. Uchida,et al.  High‐intensity focused ultrasound as salvage therapy for patients with recurrent prostate cancer after external beam radiation, brachytherapy or proton therapy , 2011, BJU international.

[14]  F. Vicini,et al.  Dose escalation improves cancer-related events at 10 years for intermediate- and high-risk prostate cancer patients treated with hypofractionated high-dose-rate boost and external beam radiotherapy. , 2011, International journal of radiation oncology, biology, physics.

[15]  Katrina Armstrong,et al.  Differences in information seeking among breast, prostate, and colorectal cancer patients: results from a population-based survey. , 2010, Patient education and counseling.

[16]  Nehama Lewis,et al.  Internet use leads cancer patients to be active health care consumers. , 2010, Patient education and counseling.

[17]  G. Barbash,et al.  New technology and health care costs--the case of robot-assisted surgery. , 2010, The New England journal of medicine.

[18]  P. Prada,et al.  Prostate‐specific antigen relapse‐free survival and side‐effects in 734 patients with up to 10 years of follow‐up with localized prostate cancer treated by permanent 125iodine implants , 2010, BJU international.

[19]  M. Menon,et al.  Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a systematic review and cumulative analysis of comparative studies. , 2009, European urology.

[20]  D. Forman,et al.  Travel time to hospital and treatment for breast, colon, rectum, lung, ovary and prostate cancer. , 2008, European journal of cancer.

[21]  Craig C Earle,et al.  Effect of distance to radiation treatment facility on use of radiation therapy after mastectomy in elderly women. , 2006, International journal of radiation oncology, biology, physics.

[22]  T. Mills,et al.  Measuring Health: A Guide to Rating Scales and Questionnaires , 2006 .

[23]  M. Barry,et al.  United States radiation oncologists' and urologists' opinions about screening and treatment of prostate cancer vary by region. , 2002, Urology.

[24]  M. Benson,et al.  Salvage cryotherapy using an argon based system for locally recurrent prostate cancer after radiation therapy: the Columbia experience. , 2001, The Journal of urology.

[25]  A. Zietman,et al.  Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer. , 2000, JAMA.

[26]  W. F. Athas,et al.  Travel distance to radiation therapy and receipt of radiotherapy following breast-conserving surgery. , 2000, Journal of the National Cancer Institute.

[27]  T. Hara,et al.  PET imaging of prostate cancer using carbon-11-choline. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.